Yizheng Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yizheng Wang has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Liang Li
Beijing Institute of Basic Medical Sciences, Beijing, China
2 shared publications - Weiming Hu
CASIA
2 shared publications - Yutong Kou
State Key Laboratory of Multimodal Artificial Intelligence System, Institute of Automation, Chinese Academy of Sciences, Beijing, China
2 shared publications Bing Li
State Key Laboratory of Multimodal Artificial Intelligence Systems (MAIS) CASIA
1 shared publicationChenggang Li
Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
1 shared publication- Chunmei Yue
State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences; University of Chinese Academy of Sciences, Shanghai, 200031, China
1 shared publication
Latest Publications
- Open Access
- 13 February 2025
- Published by Springer Nature in International Journal of Computer Vision
- Vol. 133 (7) , 3918-3950
An Experimental Study on Exploring Strong Lightweight Vision Transformers via Masked Image Modeling Pre-training
- 13 February 2025
- Published by Springer Nature in International Journal of Computer Vision
- Vol. 133 (7) , 3918-3950
Open AccessAn Experimental Study on Exploring Strong Lightweight Vision Transformers via Masked Image Modeling Pre-training
- Open Access
- 1 January 2025
- Published by Science China Press., Co. Ltd. in SCIENTIA SINICA Vitae
神经调控与脑机接口在应激相关精神疾病中的应用
神经调控技术和脑机接口(BCI)技术在应激相关精神疾病治疗中的应用日益受到关注。这些先进技术能够实时监测和精确调节大脑神经活动,为治疗抑郁症、焦虑症和创伤后应激障碍等疾病提供了新的治疗方案。经颅磁刺激(TMS)、深部脑刺激(DBS)和迷走神经刺激(VNS)等神经调控方法已在临床上显示出治疗这些疾病的潜力。此外,结合 BCI 技术,可以通过反馈机制让患者在治疗过程中实现自我调节,提高治疗的个性化和精准度。未来,这些技术的进一步发展和应用预计将为精神健康领域带来更多突破,改善患者的生活质量。
- 1 January 2025
- Published by Science China Press., Co. Ltd. in SCIENTIA SINICA Vitae
Open Access神经调控与脑机接口在应激相关精神疾病中的应用
神经调控技术和脑机接口(BCI)技术在应激相关精神疾病治疗中的应用日益受到关注。这些先进技术能够实时监测和精确调节大脑神经活动,为治疗抑郁症、焦虑症和创伤后应激障碍等疾病提供了新的治疗方案。经颅磁刺激(TMS)、深部脑刺激(DBS)和迷走神经刺激(VNS)等神经调控方法已在临床上显示出治疗这些疾病的潜力。此外,结合 BCI 技术,可以通过反馈机制让患者在治疗过程中实现自我调节,提高治疗的个性化和精准度。未来,这些技术的进一步发展和应用预计将为精神健康领域带来更多突破,改善患者的生活质量。
- Open Access
ZoomTrack: Target-aware Non-uniform Resizing for Efficient Visual Tracking
Recently, the transformer has enabled the speed-oriented trackers to approach state-of-the-art (SOTA) performance with high-speed thanks to the smaller input size or the lighter feature extraction backbone, though they still substantially lag behind their corresponding performance-oriented versions. In this paper, we demonstrate that it is possible to narrow or even close this gap while achieving high tracking speed based on the smaller input size. To this end, we non-uniformly resize the cropped image to have a smaller input size while the resolution of the area where the target is more likely to appear is higher and vice versa. This enables us to solve the dilemma of attending to a larger visual field while retaining more raw information for the target despite a smaller input size. Our formulation for the non-uniform resizing can be efficiently solved through quadratic programming (QP) and naturally integrated into most of the crop-based local trackers. Comprehensive experiments on five challenging datasets based on two kinds of transformer trackers, \ie, OSTrack and TransT, demonstrate consistent improvements over them. In particular, applying our method to the speed-oriented version of OSTrack even outperforms its performance-oriented counterpart by 0.6% AUC on TNL2K, while running 50% faster and saving over 55% MACs. Codes and models are available at https://github.com/Kou-99/ZoomTrack.
Open AccessZoomTrack: Target-aware Non-uniform Resizing for Efficient Visual Tracking
Recently, the transformer has enabled the speed-oriented trackers to approach state-of-the-art (SOTA) performance with high-speed thanks to the smaller input size or the lighter feature extraction backbone, though they still substantially lag behind their corresponding performance-oriented versions. In this paper, we demonstrate that it is possible to narrow or even close this gap while achieving high tracking speed based on the smaller input size. To this end, we non-uniformly resize the cropped image to have a smaller input size while the resolution of the area where the target is more likely to appear is higher and vice versa. This enables us to solve the dilemma of attending to a larger visual field while retaining more raw information for the target despite a smaller input size. Our formulation for the non-uniform resizing can be efficiently solved through quadratic programming (QP) and naturally integrated into most of the crop-based local trackers. Comprehensive experiments on five challenging datasets based on two kinds of transformer trackers, \ie, OSTrack and TransT, demonstrate consistent improvements over them. In particular, applying our method to the speed-oriented version of OSTrack even outperforms its performance-oriented counterpart by 0.6% AUC on TNL2K, while running 50% faster and saving over 55% MACs. Codes and models are available at https://github.com/Kou-99/ZoomTrack.
- Open Access
- 3 June 2020
- Published by Oxford University Press (OUP) in Journal of Molecular Cell Biology
- Vol. 12 (10) , 807-816
Probing the therapeutic potential of TRPC6 for Alzheimer’s disease in live neurons from patient-specific iPSCs
The induced pluripotent stem cells (iPSCs) offer an unprecedented opportunity to model and study Alzheimer’s disease (AD) under patient-specific genetic background. The lower expression of transient receptor potential canonical 6 (TRPC6) was associated with AD patients, which might be involved in AD pathogenesis. However, the role of TRPC6 that played in AD process still needs more investigation in patient-relevant neurons. In this study, the iPSCs were generated from peripheral blood cells of sporadic AD patients and efficiently differentiated into mature cortical neurons. These sporadic AD-bearing neurons displayed higher levels of AD pathological markers Aβ and phospho-tau, but lower levels of TRPC6, than those of control neurons. Treatment of AD neurons with TRPC6 protein fragment or agonist inhibited the elevation of Aβ and phospho-tau. Our results in live AD neurons manifest that the compromised expression of TRPC6 substantially contributed to Aβ pathology of sporadic AD, suggesting that targeting TRPC6 could help to develop novel therapeutic strategies for the treatments of AD.
- 3 June 2020
- Published by Oxford University Press (OUP) in Journal of Molecular Cell Biology
- Vol. 12 (10) , 807-816
Open AccessProbing the therapeutic potential of TRPC6 for Alzheimer’s disease in live neurons from patient-specific iPSCs
The induced pluripotent stem cells (iPSCs) offer an unprecedented opportunity to model and study Alzheimer’s disease (AD) under patient-specific genetic background. The lower expression of transient receptor potential canonical 6 (TRPC6) was associated with AD patients, which might be involved in AD pathogenesis. However, the role of TRPC6 that played in AD process still needs more investigation in patient-relevant neurons. In this study, the iPSCs were generated from peripheral blood cells of sporadic AD patients and efficiently differentiated into mature cortical neurons. These sporadic AD-bearing neurons displayed higher levels of AD pathological markers Aβ and phospho-tau, but lower levels of TRPC6, than those of control neurons. Treatment of AD neurons with TRPC6 protein fragment or agonist inhibited the elevation of Aβ and phospho-tau. Our results in live AD neurons manifest that the compromised expression of TRPC6 substantially contributed to Aβ pathology of sporadic AD, suggesting that targeting TRPC6 could help to develop novel therapeutic strategies for the treatments of AD.
- 1 April 2016
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
- Vol. 1859 (4) , 650-662
A dual inhibition: microRNA-552 suppresses both transcription and translation of cytochrome P450 2E1
- 1 April 2016
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
- Vol. 1859 (4) , 650-662
A dual inhibition: microRNA-552 suppresses both transcription and translation of cytochrome P450 2E1